Submit Comments: Federal Agencies Looking at How GPOs, Drug Wholesalers Influence Shortages

February 26, 2024

On February 14, the Federal Trade Commission and the U.S. Department of Health and Human Services issued a joint Request for Information on how group purchasing organizations’ and drug wholesalers’ practices are impacting the generic drug market. The Association for Clinical Oncology encourages stakeholders within the cancer community to comment to give federal agencies the perspective they need from across the myriad settings of cancer care.

Stakeholders have 60 days to submit comments. Once submitted, comments will be posted on